The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of the clinical interpretation of high-dimensional molecular data by two molecular tumor boards.
 
Damian Tobias Rieke
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alacris Theranostics; Bayer
 
Till de Bortoli
No Relationships to Disclose
 
Peter Horak
Honoraria - Ipsen
 
Mario Lamping
No Relationships to Disclose
 
Ivan Jelas
No Relationships to Disclose
 
Gina Rüter
No Relationships to Disclose
 
Johannes Berger
No Relationships to Disclose
 
Hanno Glimm
Research Funding - Bayer
Travel, Accommodations, Expenses - Illumina
 
Benedikt Brors
No Relationships to Disclose
 
Albrecht Stenzinger
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; Novartis; Thermo Fisher Scientific
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Illumina; MSD; Novartis; Roche; Takeda; Thermo Fisher Scientific
Research Funding - Bristol-Myers Squibb; Chugai Pharma
 
Stefan Fröhling
Consulting or Advisory Role - Bayer; Roche
Research Funding - AstraZeneca; Pfizer; PharmaMar
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; PharmaMar; Roche
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer Schering Pharma; Ipsen; Merck Serono; MSD Oncology; Pierre Fabre